ROAN FORGIE: Open Payments
NPI 1578744314 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,002 in 70 payments from 11 companies in 2025. Trend: 2023 $629 · 2024 $961 · 2025 $2,002
Food & beverage: $1,883Education: $119
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $505 |
| Neurocrine BioSciences, Inc. | 11 | $365 |
| Axsome Therapeutics, Inc. | 13 | $357 |
| Teva Pharmaceuticals USA, Inc. | 8 | $329 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Vanda Pharmaceuticals Inc. | 3 | $100 |
| Alkermes, Inc. | 4 | $72 |
| Lundbeck LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ABBVIE INC. | 1 | $28 |
Products named: COBENFY, INGREZZA, Auvelity, UZEDY, ABILIFY ASIMTUFII, HETLIOZ, ARISTADA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
